Home » Jordan Investors »


|| Abu Sheika Group acquires 50% of UK-based BR Pharmaceuticals

abu-sheikha.jpgJordan's Abu Sheikha Holding Group has acquired 50 percent of BR Pharmaceuticals, a UK-based firm distributing pharmaceutical, nutritional and body care products.

BR works across the UK, Europe, Middle East and African markets, supplying and marketing health and personal care brands such as vitamins and supplements to thousands of pharmacies.

To see listing and contact emails of investors from the Middle East similar to Abu Sheikha Holding, check our Middle East Investors Directory

More details follows:

Abu Sheikha Holding Group has announced it has acquired 50 percent of BR Pharmaceuticals, a leading UK-based firm, with global outreach in distributing pharmaceutical, nutritional and body care products.
The acquisition deal was signed by Chairman of Abu Sheikha Holding Group Mr. Omar Abu Sheika, while BR Pharmaceuticals was represented by its managing director and founder, Philip Byrne, in the presence of board members of the group, Ziad Abu Sheikha and Yasser Abu Sheikha, along with Jonathan Grant, the financial director of BR Pharmaceuticals.

Commenting in the deal, Mr. Abu Sheikha said it comes to reflect his company's expansion policy aimed at ensuring a strong foothold in international markets, a policy, he said, based on prudent selection of partners, targeted markets and products. He added that BR Pharmaceuticals is a big name in the field of distributing and marketing pharmaceutical products that deals in the best brands selected carefully to meet market and consumer demands.

He said: "The deal is expected to open horizons of international outreach for Abu Sheikha Drug Store, whose experience has matured in the local and regional market, paving the way for further expansion and achievement. We take into account the need to diversify our investments and network of partners, markets and targeted end users, let alone that expanding our business means more jobs for Jordanians".

For his part, Mr. Byrne said that partnership with Abu Sheikha Drug Store is a significant stride towards expanding its distribution network in the Middle East, a goal he set upon founding the firm in 1996.
He added that he has been familiar with Abu Sheikha Drug Store's experience and success story for years, voicing satisfaction with such an achievement becoming its partner.

BR works across the UK, Europe, Middle East and African markets, supplying and marketing health and personal care brands such as vitamins and supplements and home pregnancy tests to thousands of independent pharmacies, through wholesalers and distributors.



Previous Post: DubaiBeat.com an official partner of Super Return MidEast 2013 for the 6th year
Next Post: Bahrain investment firm acquires US real estate assets valued at $250 million



|| About Us

Established in 2007, DubaiBeat.com provides insight, analysis and research on Middle East investors.

We cover different asset class investors like private equity, venture capital, hedge funds and real estate investors from the Middle East and broader MENA region.


|| Subscribe












Copyright 2007-2016 DubaiBeat.com    Sitemap  |  Terms  |  Privacy Policy

Follow us: RSS Feed   Facebook    Twitter